Your browser doesn't support javascript.
loading
Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies.
van Putten, Erik H P; Kleijn, Anne; van Beusechem, Victor W; Noske, David; Lamers, Cor H J; de Goede, Anna L; Idema, Sander; Hoefnagel, Daphna; Kloezeman, Jenneke J; Fueyo, Juan; Lang, Frederick F; Teunissen, Charlotte E; Vernhout, René M; Bakker, Cathy; Gerritsen, Winald; Curiel, David T; Vulto, Arnold; Lamfers, Martine L M; Dirven, Clemens M F.
Afiliação
  • van Putten EHP; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Kleijn A; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • van Beusechem VW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Noske D; Department of Neurosurgery, Brain Tumor Center/Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Lamers CHJ; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC-Cancer Institute, Rotterdam, the Netherlands.
  • de Goede AL; Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Idema S; Department of Neurosurgery, Brain Tumor Center/Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Hoefnagel D; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Kloezeman JJ; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Fueyo J; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lang FF; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Teunissen CE; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, VU University Medical Center, Vrije Universiteit Amsterdam, the Netherlands.
  • Vernhout RM; Clinical Trial Center, Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Bakker C; Team Biosafety, Division of Safety & Environment, Support Service, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Gerritsen W; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Curiel DT; Division of Cancer Biology and Biologic Therapeutics Center, Department of Radiation Oncology, School of Medicine, Washington University in St. Louis, St. Louis, Missouri.
  • Vulto A; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Lamfers MLM; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Dirven CMF; Department of Neurosurgery, Brain Tumor Center, Erasmus University Medical Center, Rotterdam, the Netherlands.
Clin Cancer Res ; 28(8): 1572-1585, 2022 04 14.
Article em En | MEDLINE | ID: mdl-35176144
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Oncolíticos / Terapia Viral Oncolítica Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Oncolíticos / Terapia Viral Oncolítica Limite: Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda